Celgene Corporation

Form 483

Summit, New Jersey, United StatesFEI 3004991673Issued March 19, 2010

View FDA's Record for This Firm

Source: FDA record for this establishment. FDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3004991673.

Observations4

Issue DateMarch 19, 2010

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Celgene Corporation
Location: Summit, New Jersey, United States
FEI Number: 3004991673
Product Type: Drugs
Issue Date: March 19, 2010
Country: United States

Inspection History, 2017 to 2025

NAI7

VAI3

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Celgene Corporation FDA Form 483, Summit, New Jersey, March 19, 2010